undamentalytics Newsletter
Sign in

Aclarion, Inc. revenue

Aclarion, Inc.'s revenue was $75,730 in fiscal 2025, up 65.6% on the year before. Since fiscal 2021 ($60,292) it has grown at a compound 5.9% a year. Over the last twelve months it was $83,769.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue606075467684
Growth on the year before—+0.3%+24.8%−39.4%+65.6%—
Gross profit−9−5−0−39718
Gross margin−14.7%−8.0%−0.4%−85.2%9.0%21.8%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Aclarion, Inc. $83,769 33.1% 0.2%
Ispecimen Inc. $466,302 -92.1% -64.1%
YD Bio Ltd $596,817 16.9% —
Quantum-si Inc $1.6m -53.0% 51.8%
Bionexus Gene Lab Corp $3.1m -67.3% -32.9%
Seer, Inc. $14.2m -12.7% -5.1%

Compare with peers

Head to head: ACON vs ISPCACON vs YDESACON vs QSI

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Aclarion, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Aclarion, Inc.